{
    "title": "BridgeBio's heart disease drug meets late-stage study goal, shares soar",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12306673/BridgeBio-Pharmas-heart-disease-drug-meets-main-goal-late-stage-study.html",
    "date": "2023-07-17",
    "keywords": [
        "drug",
        "heart",
        "disease",
        "improvement",
        "acoramidis",
        "placebo",
        "company",
        "khushi",
        "mandowara",
        "study",
        "cardiomyopathy",
        "failure",
        "patisiran",
        "tafamidis",
        "trial",
        "hospitalization",
        "data",
        "analyst",
        "july",
        "latestage",
        "monday",
        "protein",
        "buildup",
        "review",
        "condition",
        "nod",
        "symptom",
        "polyneuropathy",
        "death",
        "distance",
        "survival",
        "frequency",
        "test",
        "tyler",
        "van",
        "buren",
        "effectiveness",
        "goal",
        "alnylam",
        "capital",
        "issi",
        "food",
        "administration",
        "fda",
        "end",
        "part",
        "marketing",
        "application",
        "year",
        "stock",
        "reporting",
        "bengaluru",
        "editing",
        "bhattacharjee",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}